Company Filing History:
1 out of 35 
1 out of 832,812 Years Active: 1989-1990
Title: The Innovations of Thomas A Ban
Introduction
Thomas A Ban is a notable inventor based in Nashville, TN (US). He has made significant contributions to the field of medicine, particularly in the treatment of Alzheimer-type dementia. With a total of 2 patents to his name, his work reflects a commitment to advancing therapeutic solutions.
Latest Patents
Thomas A Ban's latest patents include innovative approaches to treating Alzheimer-type conditions. One patent focuses on the use of sulfomucopolysaccharides in the treatment of Alzheimer-type senile dementia, highlighting the potential for these compounds to alleviate symptoms. Another patent involves amino acid and hydroxyamino acid transporter compounds, which are designed to link therapeutic compounds to amino acids or hydroxyamino acids via ester linkages, showcasing a novel method for drug delivery.
Career Highlights
Throughout his career, Thomas A Ban has worked with various companies, including Crinos Industria Farmacobiologica S.p.a. His experience in the pharmaceutical industry has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Thomas A Ban has collaborated with notable individuals in his field, including Umberto Cornelli and Thomas E Brown. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.
Conclusion
Thomas A Ban's contributions to the field of medicine through his patents and collaborations demonstrate his dedication to improving therapeutic options for patients. His work continues to inspire advancements in the treatment of Alzheimer-type conditions.